Business Standard

Top headlines: Serum, Bharat Biotech patch up; Johnson cancels India visit

From Bharat Biotech, Serum Institute patching up after war of words to PM Johnson cancels India visit, here are top headlines this morning

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Covaxin is based on highly purified and inactivated two-dose Sars-Cov-2 vaccine manufactured in a vero cell manufacturing platform

BS Web Team New Delhi
Govt ready to roll out vaccine within 10 days of emergency nod: Health secy

The health ministry is prepared to roll out the Covid vaccine within 10 days of the emergency use authorisation, which was granted to two companies on January 3. While giving this information on Tuesday, Health Secretary Rajesh Bhushan told reporters that the final date would be decided by the government. The roll-out is being planned, including the logistics and technology network, based on the feedback from the recent dry run of the vaccination process, according to Bhushan. Aadhar verification too will be a part of the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in